Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-(18)F-Fluoro-16α,17α-[(R)-(1′-α-furylmethylidene) Dioxy]-19-Norpregn-4-Ene-3,20-Dione

This first-in-human study was designed to evaluate the safety and dosimetry of the progesterone analog 21-(18)F-fluoro-16α,17α-[(R)-(1′-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione ((18)F-FFNP), as well the feasibility of imaging tumor progesterone receptors (PRs) by PET in breast cancer....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dehdashti, Farrokh, Laforest, Richard, Gao, Feng, Aft, Rebecca L., Dence, Carmen S., Zhou, Dong, Shoghi, Kooresh I., Siegel, Barry A., Katzenellenbogen, John A., Welch, Michael J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3595048/
https://ncbi.nlm.nih.gov/pubmed/22331216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.111.098319
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares